CDH1 and breast carcinoma: Given that a decrease of E-cadherin is associated with increased metastatic potential of tumor cells [32], our result showing that β2-chimaerin reduces E-cadherin is paradoxical, since it had been reported the inhibition of migration and invasion of breast cancer cells by β2-chimaerin [22].